Molecular Diagnostics
Recurrent Disease Following DCIS Unrelated to Initial Lesions
Ductal carcinoma in situ (DCIS) is the most common form of pre-invasive breast cancer and, despite treatment, a small fraction (5% to 10%) of DCIS patients develop subsequent invasive disease. While DCIS are generally low-grade lesions that do not progress, a small portion of patients do experience recurrence, even after treatment. More...15 Jun 2022
Serological Biomarker Aids Diagnosis of Rare Kidney Disease Without Biopsy
Antibodies against PLA2R (phospholipase A2 receptors) have been recognized as a significant serological biomarker for the diagnosis of primary membranous nephropathy (pMN) and can be determined using exclusive test systems from EUROIMMUN (Luebeck, Germany), a PerkinElmer, Inc. (Waltham, MA; USA) company. More...15 Jun 2022
Automated Extraction of Ultra High Molecular Weight DNA
Hamilton (Reno, NV, USA) and Bionano Genomics (San Diego, CA, USA) have announced the collaborative development of the Long String VANTAGE for the isolation of Ultra High Molecular Weight (UHMW) DNA for use in optical genome mapping (OGM). More...15 Jun 2022
Genetic Polymorphisms Related to Recurrent Pregnancy Loss
Recurrent pregnancy loss (RPL) is defined as experiencing two or more spontaneous miscarriages occurring within 20 weeks of gestation and was reported to affect up to 1%–5% of women of reproductive age seeking pregnancy. The causes are unidentifiable in 50% of the patients who are classified as experiencing unexplained recurrent pregnancy loss (URPL). More...13 Jun 2022
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Urine Chemistry Control
Dropper Urine Chemistry Control
In Other News
POC Diagnostic Respiratory Panel Tests for Presence of Multiple Viruses and Bacteria
Biobank Samples for Genetic Testing to Enable Accurate Diagnosis of Rare Diseases
Automated Nucleic Acid Test (NAT) System Screens Blood Donors for Malaria
Thermo Scientific Launches Blood Tests for Diagnosing Autoimmune Disease
First Blood-Based Diagnostic Test for Bipolar Disorder Also Differentiates Patients with Depression
Novel Method for Fast Detection of Key Antiviral to Speed Hepatitis Diagnosis
Detection of ctDNA Can Guide Post-Surgical Treatment of Colon Cancer Patients
New Tool Improves Ebola Virus Diagnosis
New Way to Identify Influenza A Virus Could Pave Way for More Sensitive Tests
Randox Quality Control Launches Acusera Anti-Müllerian Hormone (AMH) Control
Blood Test Combines Epigenetics, NGS and Machine Learning for Multi-Cancer Early Detection
Quantitative Diagnostic System Delivers Results in Minutes at True POC Situation
Biodesix’s MRD Test for Solid Tumors to Run on Bio-Rad's Upcoming QX600 ddPCR System
Blood Test Enables Early Detection of Oral Cancer
MIS-C Linked to Rare, Immune-Related Variants
Noninvasive Blood Test Predicts Rejection After Heart Transplant
Genome-Wide NIPT Uncovers Additional Findings
Proteomics-based Blood Test May Replace Biopsy for Diagnosis of Liver Disease
Novel Method Uses DNA Droplets for Early Disease Detection
Testing for DNA Shed from Colon Cancers into Bloodstream Guides Chemotherapy After Surgery
Blood Test May Be a Game-Changer for TB Diagnoses and Treatment
Blood Test Detects and Monitors Cell Death to Predict Disease Severity
Non-Invasive Tests for Diagnosing Liver Diseases Could Shape Future Clinical Care
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
